Why the study?
Does EVOQUE TTVR improve clinical and echocardiographic outcomes in patients with symptomatic severe mechanically induced TR?
Observational (n=13)
Yes
Does EVOQUE TTVR improve clinical and echocardiographic outcomes in patients with symptomatic severe mechanically induced TR?
Transcatheter tricuspid valve replacement with the EVOQUE system is feasible and improves quality of life in patients with complex, mechanically induced tricuspid regurgitation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) conducted an observational in Symptomatic severe or greater tricuspid regurgitation (n=13). EVOQUE Transcatheter Tricuspid Valve Replacement (TTVR) was evaluated on TTVR procedural success.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: